HUP0700809A2 - Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate - Google Patents
Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediateInfo
- Publication number
- HUP0700809A2 HUP0700809A2 HU0700809A HUP0700809A HUP0700809A2 HU P0700809 A2 HUP0700809 A2 HU P0700809A2 HU 0700809 A HU0700809 A HU 0700809A HU P0700809 A HUP0700809 A HU P0700809A HU P0700809 A2 HUP0700809 A2 HU P0700809A2
- Authority
- HU
- Hungary
- Prior art keywords
- dihydrothieno
- pyridin
- chlorophenyl
- alpha
- acetate
- Prior art date
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0700809A HUP0700809A2 (en) | 2007-12-14 | 2007-12-14 | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate |
PCT/HU2008/000148 WO2009077797A1 (en) | 2007-12-14 | 2008-12-11 | Racemization process for the preparation of an intermediate of clopidogrel hydrogen sulphate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0700809A HUP0700809A2 (en) | 2007-12-14 | 2007-12-14 | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate |
Publications (2)
Publication Number | Publication Date |
---|---|
HU0700809D0 HU0700809D0 (en) | 2008-02-28 |
HUP0700809A2 true HUP0700809A2 (en) | 2009-11-30 |
Family
ID=89987939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0700809A HUP0700809A2 (en) | 2007-12-14 | 2007-12-14 | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP0700809A2 (en) |
WO (1) | WO2009077797A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111166745A (en) * | 2020-01-19 | 2020-05-19 | 成都施贝康生物医药科技有限公司 | Composition containing racemic oxypyramine or salt thereof and application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL166593A0 (en) * | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel |
-
2007
- 2007-12-14 HU HU0700809A patent/HUP0700809A2/en unknown
-
2008
- 2008-12-11 WO PCT/HU2008/000148 patent/WO2009077797A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
HU0700809D0 (en) | 2008-02-28 |
WO2009077797A1 (en) | 2009-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007125544A3 (en) | Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate | |
IL185510A0 (en) | Fused thieno [2,3-b] pyridine and thiazolo [5,4-b] pyridine compounds for inhibiting ksp kinesin activity | |
ZA201005554B (en) | Furo-and thieno[3,2-c]pyridines | |
IL189667A0 (en) | 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
IL177805A0 (en) | A method for preparing thieno[3,2-c]pyridine derivatives | |
ZA200504238B (en) | Thieno[3,2-b]pyridine-6-carbonitriles and thienoo[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
ZA200802690B (en) | Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
HK1122808A1 (en) | Preparation and use of tetrahydropyrrolo [3, 2-c]t pyridin-4-one derivatives for treatment of obesitty, psychiatric and neurological disorders | |
PL2112155T3 (en) | Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation | |
HK1159628A1 (en) | Thieno[3,2-c]pyridine derivatives as kinase inhibitors for use in the treatment of cancer [32- c] | |
IL181387A0 (en) | Fused tricyclic derivatives for the treatment of psychotic disorders | |
SI1513846T1 (en) | Process of preparation of olanzapine form i | |
EP2062895A4 (en) | Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof | |
EP1651646A4 (en) | A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i | |
HU0600194D0 (en) | Process for producing (s)-(+)-methyl-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetate hidrogen sulfate polimorph i | |
ZA200608569B (en) | Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide | |
HU0700809D0 (en) | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate | |
UA84335C2 (en) | Clopidogrel salt and polymorphic forms thereof | |
ZA201000627B (en) | 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1h-pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors | |
PL354642A1 (en) | Method of manufacture of alanzapine, new derivative of n-demethyl olanzapine and method of manufacture of new derivative of n-demethyl olanzapine | |
WO2007087555A3 (en) | Novel polymorph 'form e ' of olanzapine (2-methyl-4- (4-methyl-1-piperazinyl) -10h-thieno [2, 3-b] [1, 5] benzodiazepine) and preparation of the anhydrous non-solvated crystalline polymorphic 'form i' of olanzapine from the polymorphic olanzapine 'form e' | |
SG113595A1 (en) | New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them | |
PL380849A1 (en) | Crystalline form of racemic methyl 0 - (2-chlorophenyl) - 6, 7 - dihydrothiene [3, 2 - c] pyridil -5 (4H) - acetate, method for its manufacture and its application | |
WO2008108742A3 (en) | Polymorphic forms of clopidogrel hydrobromide | |
EA201290535A1 (en) | METHOD FOR OBTAINING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |